Skip to main content

James Bylund

Equibles does not estimate personal net worth.

Get an email with a short summary when Repligen Corp publishes a filing, an earnings call transcript or a press release.

Get RGEN alerts

About James Bylund

James Bylund is recorded as COO at Repligen Corp (RGEN). The newest filing on record that lists James Bylund as COO at Repligen Corp (RGEN) is dated April 2, 2026. The proxy statement of Repligen Corp reports total compensation of $2,932,519 for James Bylund in fiscal 2025, including a base salary of $481,197. Disclosed compensation is on record for 5 fiscal years. Repligen Corp is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Repligen Corp includes Olivier Loeillot (CEO and Board Member), Dr. Martin D. Madaus (Chairman and Board Member), Martin D. Madaus (Chairman) and 7 others.

Affiliation history

  • Repligen Corp (RGEN)

    COO

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 2, 2026

  • Repligen Corp (RGEN)

    Proxy statement

    Start not stated–2021-04-21

    Last confirmed by a filing; no departure on record

Company network

Current role

Medical Instruments & Supplies · Healthcare

COO

Leadership on record at Repligen Corp

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Repligen Corp (RGEN) $481,197 $2,932,519
2024 Repligen Corp (RGEN) $467,181 $4,170,772
2023 Repligen Corp (RGEN) $467,181 $3,743,430
2022 Repligen Corp (RGEN) $424,710 $2,378,322
2021 Repligen Corp (RGEN) $363,000 $1,843,687

Recent activity

No call appearances or filed executive changes recorded yet.